Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Link
http://link.springer.com/content/pdf/10.1186/1471-2407-8-216.pdf
Reference20 articles.
1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55 (2): 74-108.
2. Ho C, Davies AM, Lara PN, Gandara DR: Second-line treatment for advanced-stage non-small-cell lung cancer: current and future options. Clin Lung Cancer. 2006, 7 (Suppl 4): S118-25.
3. Wakelee H, Belani CP: Optimizing first-line treatment options for patients with advanced NSCLC. Oncologist. 2005, 10 (Suppl 3): 1-10. 10.1634/theoncologist.10-90003-1.
4. Walling J: Chemotherapy for advanced non-small-cell lung cancer. Resp Med. 1994, 88: 649-657. 10.1016/S0954-6111(05)80061-7.
5. Molina JR, Adjei AA, Jett JR: Advances in chemotherapy of non-small cell lung cancer. Chest. 2006, 130 (4): 1211-9. 10.1378/chest.130.4.1211.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer;Clinical Pharmacology & Therapeutics;2022-02-21
2. Pathogenesis and therapeutic strategy in platinum resistance lung cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-08
3. Preparation and Evaluation of Stearylamine-Bearing Pemetrexed Disodium-Loaded Cationic Liposomes In Vitro and In Vivo;AAPS PharmSciTech;2020-07
4. The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer;Expert Opinion on Pharmacotherapy;2018-10-24
5. Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect;International Journal of Nanomedicine;2018-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3